New ultrasound methods that can be used to quantitatively assess liver fat content have
recently been developed. These quantitative ultrasound (QUS) methods are based on the …

Background Diagnostic tools for liver disease can now include estimation of the grade of
hepatic steatosis (S0 to S3). Controlled attenuation parameter (CAP) is a non-invasive …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Chronic liver diseases (CLDs) are a public health problem, even if frequently they are
underdiagnosed. Hepatic steatosis (HS), encountered not only in nonalcoholic fatty liver …

Background Non-alcoholic fatty liver disease (NAFLD) is increasingly common in the adult
population. In the United States, the overall burden of NAFLD is unknown due to challenges …

Non-alcoholic fatty liver disease (NAFLD) is the emerging cause of chronic liver disease
globally and lack of approved therapies. Here, we investigated the feasibility of …

Background Concomitant chronic hepatitis B infection (CHB) and non-alcoholic fatty liver
disease (NAFLD) is common, but the implications of NAFLD on clinical outcomes of CHB …

Background: Vitamins and carotenoids may be involved in the pathogenesis of non-
alcoholic fatty liver disease (NAFLD). Previously related publications mainly focused on …

Our understanding of fatty liver syndromes and their relationship with the metabolic
syndrome has improved over recent decades and, paralleling this, we are now at the dawn …

Background Noninvasive methods have been used for the assessment of hepatic steatosis
in patients with nonalcoholic fatty liver disease (NAFLD). The aim was to assess the efficacy …